A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor ...

They kill cancer cells consistently over a long period,” said senior author Dr. Nabil ... “We need to understand what’s happening at the molecular level so we can engineer CAR T cells to adapt their ...

Researchers have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them ...

A car can move, it gets energy from petrol ... solution to the layer carefully place a cover slip over the layer When you observe cells, it is usual to make a drawing of what you see.

Larger studies are needed to assess efficacy, but early data suggest this approach could offer a less toxic alternative to CAR-T cell therapies that are approved by the Food and Drug ...

CAR T cell therapy has revolutionized cancer care, providing a powerful option for some blood cancers. No treatment is perfect, however, and some patients develop resistance to CAR T cell therapies.